RVL Pharmaceuticals plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVLP research report →
Companywww.rvlpharma.com
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022.
- CEO
- Brian A. Markison
- IPO
- 2018
- Employees
- 125
- HQ
- Bridgewater, NJ, US
Price Chart
Valuation
- Market Cap
- $3.14M
- P/E
- -0.05
- P/S
- 0.06
- P/B
- 0.05
- EV/EBITDA
- -0.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 80.98%
- Op Margin
- -91.87%
- Net Margin
- -103.96%
- ROE
- -80.88%
- ROIC
- -41.26%
Growth & Income
- Revenue
- $49.72M · 184.10%
- Net Income
- $-51,692,000 · 37.61%
- EPS
- $-0.58 · 52.85%
- Op Income
- $-45,680,000
- FCF YoY
- 31.77%
Performance & Tape
- 52W High
- $1.66
- 52W Low
- $0.00
- 50D MA
- $0.09
- 200D MA
- $0.66
- Beta
- 1.09
- Avg Volume
- 24.42M
Get TickerSpark's AI analysis on RVLP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 19, 23 | Harsaul Foundation | sell | 9,363,760 |
| Oct 20, 23 | Harsaul Foundation | sell | 4,758,899 |
| Oct 19, 23 | Altchem Ltd | sell | 9,363,760 |
| Oct 20, 23 | Altchem Ltd | sell | 4,758,899 |
| Oct 18, 23 | Harsaul Foundation | sell | 3,421,537 |
| Oct 18, 23 | Altchem Ltd | sell | 3,421,537 |
| Aug 15, 23 | Avista Healthcare Partners GP, Ltd. | other | 23,730,864 |
| Aug 10, 23 | Lask Alisa | other | 12,000 |
| Jul 5, 23 | DeBiasi Michael J. | other | 40,000 |
| Jul 5, 23 | COWAN GREGORY L | other | 40,000 |
Our RVLP Coverage
We haven't published any research on RVLP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RVLP Report →